Home > PS Ratio > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
PS (Price/Sales) Ratio

The Current P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 74.58.

Share Price ₹165.0Jun 10,2025
Market Cap ₹5,352.6 Cr
Sales-TTM₹71.8 CrTTM-Consolidated Results
Price/Sales74.58xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is calculated as :

Current Market Cap [ ₹5,352.6 Cr] as on Jun 10,2025

(/) Sales [ ₹71.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 74.58x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SUN PHARMA ADVANCED RESEARCH COMPANY , the investors are currently willing to pay '74.58 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMA ADVANCED RESEARCH COMPANY !

The chart below summarizes the trend in P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY over the last five years.

Historical PS (Price/Sales) ratio chart of SUN PHARMA ADVANCED RESEARCH COMPANY


PS Ratio Performance Analysis for SUN PHARMA ADVANCED RESEARCH COMPANY

- SUN PHARMA ADVANCED RESEARCH COMPANY 's latest p/e ratio is 74.58x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio for fiscal years ending Mar2024 to Mar2023 averaged 91.66x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's operated at median p/e ratio of 158.92x from fiscal years ending March 2018 to 2022.

- Looking back at the last 2 fiscal years, SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio peaked in Mar2024 at 158.92x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio hit its five-year low in Mar2023 of 24.39x.


How does SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio benchmark against top 10 peers in Business Support Industry?

Peer Comparison (Business Support Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SUN PHARMA ADVANCED RESEARCH COMPANY 71.874.585,352.6
SYNGENE INTERNATIONAL LTD3,642.47.2826,511.4
SAGILITY INDIA LTD5,629.83.3819,024.9
LATENT VIEW ANALYTICS LTD847.810.048,509.7
JUST DIAL LTD1,042.97.487,805.4
AWFIS SPACE SOLUTIONS LTD1,207.54.094,937.5
MEDI ASSIST HEALTHCARE SERVICES LTD723.34.943,571.4
JAYKAY ENTERPRISES LTD80.625.312,041.1
ECOS (INDIA) MOBILITY & HOSPITALITY LTD654.02.931,919.1
RK SWAMY LTD294.33.36990.1
KRYSTAL INTEGRATED SERVICES LTD1,212.80.70842.9

Business Support Industry Benchmark (Top 10) PS Analysis vs SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.70x
Max industry PS 74.58x
Median industry PS 4.94x
Average industry PS 13.10x



You may also like the below Video Courses